Bonus Sessions

Join GI physicians from the U.S. and around the world for the ACG Annual Scientific Meeting. ACG 2022 will deliver the latest clinical information on timely topics in gastroenterology and hepatology.

ACG Annual Scientific Meeting Optional Bonus Sessions

Add this optional package to your Annual Scientific Meeting registration for even more first-class education that provides an additional 25 hours of CME/MOC credit! This add-on provides access to over 70 recorded presentations (and slides) from 24 Bonus Sessions (topics listed below). These Bonus Sessions are pre-recorded narrations by faculty of their presentation slides, and will be available to watch on-demand on the ACG 2022 Conference Platform, from October until March 31, 2023.

You must register for the Annual Scientific Meeting in order to purchase the optional Annual Scientific Meeting Bonus Sessions package. Both in-person and virtual registrants can purchase this add-on package.

Bonus Sessions

Separate Purchase Required: You must register for the Annual Scientific Meeting in order to purchase the optional Annual Scientific Meeting Bonus Sessions package. Both in-person and virtual registrants can purchase this add-on package.

Bonus Session A: ACG Liver Guidelines
Moderator: Alexandra Shingina, MD
  • Alcohol-Associated Liver Disease
    Ashwani K. Singal, MD, MS, FACG
    Apply the current evidence-based guidelines in the diagnosis and management of alcohol-associated liver disease.
  • Acute Liver Failure vs Acute-on-Chronic Liver Failure
    Alexandra Shingina, MD
    Distinguish acute liver failure from acute-on-chronic liver failure, and apply evidence-based strategies for management  of these patients.
  • Hemochromatosis
    Manida Wungjiranirun, MD
    Describe the diagnosis and management of patients with iron overload.
Bonus Session B: Multidisciplinary Management of the Four Challenging P’s of IBD: Perianal Crohn’s, Peristomal, Proctitis, and Pouchitis
Moderator: David A. Schwartz, MD, FACG
  • Perianal Crohn’s Disease
    David A. Schwartz, MD, FACG
    Summarize best practices and emerging therapies for medical and surgical management of perianal Crohn’s disease.
  • Peristomal Complications
    Virginia Hanchett, NP, WOCN
    Recognize peristomal complications of IBD and identify appropriate management strategies.
  • Proctitis (Moderate to Severe)
    Amanda M. Johnson, MD
    Describe the role of topical, oral, and immunosuppressive therapies for the management of refractory proctitis.
  • Pouchitis
    Maia Kayal, MD
    Highlight strategies to address pouchitis beyond antibiotics.
Bonus Session C: Emerging Uses of Technology in Gastroenterology
Moderator: Folasade P. May, MD, PhD, MPhil
  • Leveraging Social Media to Advance Health Equity in Gastroenterology
    Folasade P. May, MD, PhD, MPhil
    Explain how social media can be used to improve health equity.
  • Leveraging Social Media to Learn, Educate, and Enhance Your Practice/Brand
    Amy S. Oxentenko, MD, FACG
    Demonstrate ways to use social media to maximize the impact to your patients and practice.
  • Virtual Reality: A New Therapeutic Modality?
    Brennan M. Spiegel, MD, MSHS, FACG
    Define the role of virtual reality in the therapeutics of various GI conditions.
Bonus Session D: Onco-Gastroenterology: What You Need to Know About GI Toxicity of Novel Cancer Therapies and Genetic Testing
Moderator: Shilpa Grover, MD, MPH
  • GI Toxicity of Emerging Cancer Therapies: Targeted Therapy, Checkpoint Inhibitors, and Beyond
    Shilpa Grover, MD, MPH
    Recognize the spectrum of GI toxicity of molecular-targeted agents, checkpoint inhibitors, and emerging cancer treatment modalities, and formulate strategies for management.
  • Checkpoint-Inhibitor Hepatitis
    Joseph K. Lim, MD, FACG
    Outline an approach to identify and manage patients with checkpoint-inhibitor hepatitis.
  • Next Generation Sequencing: Genetic Testing to Identify High-Risk Patients and Guide Screening
    Aparajita Singh, MD
    Recognize the indications for genetic evaluation and the role of next generation sequencing to guide management of hereditary gastrointestinal cancer syndromes.
Bonus Session E: Management of the Pregnant Patient
Moderator: Sunanda V. Kane, MD, MSPH, FACG
  • Special Considerations in the Performance of Endoscopy in the Pregnant Patient
    Eugenia Shmidt, MD
    Outline key aspects in the performance of endoscopic procedures in pregnant patients.
  • Management of the Pregnant IBD Patient
    Sunanda V. Kane, MD, MSPH, FACG
    Discuss the different management strategies of IBD during pregnancy.
  • Liver Disease and Pregnancy
    Nancy S. Reau, MD, FACG
    Describe the evaluation and management of a variety of liver diseases manifesting during pregnancy.
Bonus Session F: Advances in Acute Pancreatitis: Fluids, Feeds, and Future Complications
Moderator: Jodie A. Barkin, MD
  • The First 24 Hours: Insights in Fluid Management in Acute Pancreatitis
    Anna Evans Phillips, MD
    Evaluate the evidence for rehydration strategies in the early management of acute pancreatitis.
  • NPO on Day 3 No More: Early Re-Initiation of Enteral Nutrition in Acute Pancreatitis
    Darwin L. Conwell, MD, MS, FACG
    Examine the data for nutritional complications in acute pancreatitis and describe approaches to early refeeding with acute pancreatitis.
  • Long-Term Sequelae of Acute Pancreatitis: Exocrine and Endocrine Pancreatic Insufficiency
    Jodie A. Barkin, MD
    Identify patients at risk for exocrine pancreatic insufficiency and diabetes after acute pancreatitis and discuss appropriate management strategies.
Bonus Session G: Gastroparesis and Functional Dyspepsia in 2022
Moderator: David Armstrong, MD, FACG
  • The Latest and Greatest: ACG’s New Gastroparesis Guidelines
    David Armstrong, MD, FACG
    Outline the newest ACG guidelines for the diagnosis and management of gastroparesis.
  • Two Sides of the Same Coin: Sliding Along the Functional Dyspepsia/Gastroparesis Spectrum
    Lavanya Viswanathan, MD, MS
    Describe the distinguishing and overlapping features of functional dyspepsia and gastroparesis.
  • Making Sense of When to Use Pyloric Interventions
    Jennifer A. Christie, MD
    Recognize the applications and limitations of pyloric therapies for gastroparesis.
Bonus Session H: You CAM Do It! Alternative Approaches to Digestive Care
Moderator: Linda Ahn B. Nguyen, MD, FACG
  • Cannabinoids: Turn On, Tune In, Drop Out
    Edith Y. Ho, MD, MS, FACG
    Identify the therapeutic uses of cannabinoids in GI and recognize potential pitfalls.
  • Your Patients Are Taking Them Anyway: Understanding Nutraceuticals in DGBIs
    Linda Ahn B. Nguyen, MD, FACG
    Summarize the evidence behind common and popular nutraceuticals on the market.
  • There’s an App for That: Evaluating the Digital App Landscape in GI
    Eric D. Shah, MD, MBA, FACG
    Analyze available apps for clinical use in GI for both physician and patient.
Bonus Session I: Blood, Bowel, and Biomarkers: From Selection to Monitoring in IBD
Moderator: Adjoa N. Anyane-Yeboa, MD, MPH
  • Discussion of Risks and Positioning of Therapy in IBD
    Meenakshi Bewtra, MD, PhD, MPH
    Recognize safety and risks of therapy balanced with positioning of treatment options.
  • Lab Testing for Treatment and Disease Monitoring Strategies
    Adjoa N. Anyane-Yeboa, MD, MPH
    Interpret lab testing and monitoring strategies to optimize disease management.
  • Therapeutic Drug Monitoring in IBD
    Andres J. Yarur, MD, FACG
    Explain drug and antibody level monitoring strategies with both TNF and non-TNF antagonist therapies.
Bonus Session J: Interventional Colonoscopy: What Gastroenterologists Need to Know
Moderator: Mohamed O. Othman, MD
  • Basic Polypectomy Techniques: Cold or Hot Snare or Forceps?
    Saowanee Ngamruengphong, MD
    Identify options for colon polyp resection, and when to employ specific techniques.
  • Advanced Endoscopic Resection: When Basic Isn’t Enough
    Mohamed O. Othman, MD
    Apply advanced techniques to facilitate comprehensive endoscopic resection of challenging polyps.
  • Endoscopic Evaluation and Management of IBD and Complications
    Gursimran S. Kochhar, MD
    Explain the role of advanced endoscopic imaging and interventions in the management of IBD and its complications.
Bonus Session K: Leadership, Diversity, Ethical Care, and Equity
  • Comprehensive Care of Common GI Conditions for LGBTQI+ Communities
    Sonali Paul, MD, MS
    Explain how practitioners can appropriately care for members of the LGBTQI+ community.
  • Allyship for URMs in GI Challenges and Solutions to Satisfy an Unmet Need
    Cassandra D. Fritz, MD
    Identify ways that allies can support underrepresented minorities in medicine.
  • The Impact of the Social and Structural Determinants of Health on Vulnerable Populations With Chronic Liver Disease Epidemiology and Solutions
    Lauren D. Nephew, MD
    Describe the barriers to healthcare faced by vulnerable populations and how providers can assist these
Bonus Session L: Celebrating Women in GI
  • Promoting Gender Diversity in Non-Clinical Realms: Engaging Women in Research and Authorships
    Millie D. Long, MD, MPH, FACG
    Appraise high-impact publications led by female physician scientists.
  • It’s Time to Break Another Glass Ceiling: Women and Interventional Endoscopy
    Allison R. Schulman, MD, MPH
    Discuss barriers that women face in pursuing advanced endoscopy training, and recent inroads that have been made.
  • Ergonomics in Endoscopy – What Do Women Do Differently?
    Asmeen Bhatt, MD, PhD
    Demonstrate gender differences in endoscopy preferences and work-related physical injury.
Bonus Session M: Complications of Portal Hypertension
  • Recent Updates in the Management of Varices
    Uchenna A. Agbim, MD
    Describe updated medical and interventional therapies for the management of varices.
  • Portal and Hepatic Vein Thrombosis
    Joseph Ahn, MD, MS, MBA, FACG
    Recognize diagnostic, surveillance, and treatment strategies for portal and hepatic vein thrombosis.
  • Acute Kidney Injury in Cirrhosis: Everything is Not Hepatorenal Syndrome
    Patricia L. Bloom, MD
    Identify and manage acute kidney injury in patients with cirrhosis.
Bonus Session N: Fatty Liver Disease
  • NAFLD vs. MAFLD: What’s in a Name?
    Robert J. Wong, MD, MS, FACG
    Discuss the differences between nonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated liver disease (MAFLD) nomenclature and its relevance to clinical management.
  • Emerging Medical Therapies for ALD and NAFLD
    Mary E. Rinella, MD, FACG
    Evaluate recent advances in new and emerging treatments for the management of alcohol-associated liver disease and nonalcoholic fatty liver disease.
  • In Search of the Optimal NAFLD Clinical Care Pathway
    Joseph K. Lim, MD, FACG
    Describe the effectiveness of optimal clinical care models in improving the NAFLD care cascade from early diagnosis to management.
Bonus Session O: Cystic Neoplasms of the Pancreas
  • Diagnostic Evaluation of Pancreatic Cystic Lesions
    V. Raman Muthusamy, MD, MS, FACG
    Compare key aspects of the diagnostic evaluation of pancreatic cysts lesions including radiologic and endoscopic imaging, fluid analysis and tissue acquisition.
  • Surveillance of Pancreatic Cystic Neoplasms: Making Sense of the Guidelines
    Anne Marie Lennon, MD, PhD, MBBCh, FACG
    Explain and summarize the similarities and key differences among existing guidelines.
  • Update on Endoscopic Ultrasound-Guided Cyst Ablation
    John M. DeWitt, MD, FACG
    Describe key features of EUS-guided ablation including patient selection, choice of ablative agent and adverse events.
Bonus Session P: Let’s Bring Nutrition Back to the Gastroenterology Clinic
  • Identification and Evaluation of Malnutrition in a Gastroenterology Practice
    Dejan Micic, MD
    Identify screening strategies for malnutrition and the basic interventions in a malnourished patient.
  • What Happens After a PEG? Basics of Enteral Nutrition Support
    Shirley C. Paski, MD
    Explain the basic principles of the provision of enteral nutrition.
  • My Tube is Leaking…Complications and Management of Troublesome Enteral Tubes
    John C. Fang, MD
    Define the basic complications of enteral tube placement and the management of troublesome tubes.
Bonus Session Q: Practicing GI in 2022: What Does the Physician Need to Do to Prepare?
  • The Great Recalibration of 2022: Is it Time for a Career Change and What Does That Mean?
    Vonda G. Reeves, MD, MBA, FACG
    Evaluate your current professional role and assess alignment with long-term goals and ambitions.
  • Are You Professionally Exhausted? What Is it and How Can I Fix the Problem?
    David J. Hass, MD, FACG
    Identify signs of professional exhaustion and develop strategies to mitigate this in the short- and long-term.
  • Keeping Your Career Sharp: How to Keep Yourself Invigorated and Excited for Your Future
    Sunanda V. Kane, MD, MSPH, FACG
    Outline innovative methods to enhance your career path for long-term career satisfaction and achievement.
Bonus Session R: Controversies in the Management of Female Pelvic Floor Disorders
  • Leave It to GI: Medical Management Is Best!
    Leila Neshatian, MD, MSc
    Describe the medical therapies available for common pelvic floor disorders including novel medical and device therapies.
  • The Only Thing That Heals Is Cold Steel: Sometimes Only Surgery Will Do
    Tracy Hull, MD
    Identify which patients with pelvic floor disorders are suitable candidates for surgery.
  • Pelvic Floor Physical Therapy and Biofeedback First
    Jen Shifferd, PT, CLT, WCS
    Discuss the best uses and limitations of pelvic floor physical therapy and biofeedback.
Bonus Session S: Emerging Issues in Alcohol-Associated Liver Disease
  • Changing Epidemiology Worldwide and in the COVID Era
    Renumathy Dhanasekaran, MD
    Describe the global healthcare burden of ALD in the COVID-19 era.
  • Updates in the Management of Alcohol-Associated Hepatitis
    Binu V. John, MD, MPH, FACG
    Outline the current medical treatment options for and recognize the evolving role of liver transplantation in patients with alcohol-associated hepatitis.
  • Integrated Care Model for Alcohol-Associated Liver Disease
    Ashwani K. Singal, MD, MS, FACG
    Recognize the dual pathology of liver disease and alcohol use disorder in patients with alcohol-associated liver disease and demonstrate the role of integrated care in improving their long-term outcome.
Bonus Session T: Evaluating Evidence-Based Medicine: Exploring ACG's Newest Publication, “Evidence-Based GI”
  • Introducing the New ACG Evidence-Based GI Publication and Why It Matters
    Jessica Allegretti, MD, MPH, FACG
    Explain the concept and the utility of the new evidence based journal review.
  • How to Review Articles and Evidence Using GRADE Methodology
    Robert J. Wong, MD, FACG
    Recognize how to assess scientific publications and the impact they should have on clinical practice.
  • Highlighting High-Impact GI Articles From the Inaugural Year
    Philip Schoenfeld, MD, MSEd, MSc(Epi), FACG
    Summarize the high-impact articles covered in the ACG Evidence-Based GI publication.
Bonus Session U: “Post”-Covid-19: What Should Stay and What Should Change in the Practice of GI?
  • The Financial and Emotional Impact of COVID-19 on GI Practice
    Harish K. Gagneja, MD, FACG
    Explain the financial and psychological burdens of the pandemic on GI practice.
  • Changes in Practice Management Due to the Pandemic
    Daniel J. Pambianco, MD, FACG
    Discuss the scheduling, clinic visits, and endoscopic procedural changes made due to the pandemic and which ones will or should become permanent.
  • Virtual Platforms for Interviews, Education, and Conference Participation
    Amy S. Oxentenko, MD, FACG
    Identify the changes in practice and education with the increase in virtual interactions and suggest which should continue and how they will evolve after the pandemic. 
Bonus Session V: A New Take on Celiac Disease – Updates on the Diagnosis and Management
  • First, Let’s Make the Diagnosis
    Ciarán P. Kelly, MD, FACG
    Explain the role of serology and endoscopy for the diagnosis of celiac disease in adult patients.
  • Novel Therapies for Celiac Disease
    Joseph A. Murray, MD, FACG
    Examine the upcoming therapies for celiac disease and their role in disease management.
  • Diagnosis and Management of Refractory Celiac Disease
    Peter H.R. Green, MD, FACG
    Evaluate the presentation, diagnostic criteria, and management of refractory celiac disease.
Bonus Session W: Sustainability in GI
  • What Is Climate Change and How Will it Impact GI?
    Desmond Leddin, MBBCh, FRCPC
    Describe the causes of climate change and state the effects which global warming will have on digestive health.
  • Climate Change from the Health and Healthcare Systems Perspective
    Bishr Omary, MD, PhD
    Explain the circular relationship of climate change, health and healthcare systems, and recognize the importance of decarbonizing health care systems and comprehend national and international approaches to achieving this goal.
  • The Role of Environmental Ethics in Endoscopic Decision-Making
    Nitin K. Ahuja, MD, MS
    Identify the incentives, ethical and otherwise, prioritized by the current status quo of individualized clinical decision-making, and evaluate the feasibility of including sustainability and justice concerns into future models of healthcare delivery.
  • How to Reduce the Carbon Footprint of Your GI Academic and Community Practice
    Swapna Gayam, MD, FACG
    Discuss the contribution of GI and endoscopy towards climate change and identify immediately implementable tips and steps to begin reducing the carbon footprint and reducing waste in practice.
Bonus Session X: A Deep-Dive into Central Neuromodulators
  • Neuromodulators for Functional GI Disorders – A Presentation and Panel Discussion
    Speaker: Douglas A. Drossman, MD, MACG
    Panelists: Lin Chang, MD, FACG; Douglas A. Drossman, MD, MACG; Albena D. Halpert, MD; Johannah Ruddy, Med; Gregory S. Sayuk, MD, MPH

    Discuss disorders of the gut-brain interaction and how neuromodulators may help these patients.